Retrieve available abstracts of 31 articles: HTML format
Single Articles
March 2025
PAUL R, Lorenzo F, Lopez B, Alegre MG, et al Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual
Combination of Resistance Mutations, Northern Argentina, 2006-2022.
Emerg Infect Dis. 2025;31:601-606. PubMedAbstract available
KLINKENBERG E, de Haas P, Manyonge C, Namutebi J, et al Lessons Learned from Early Implementation and Scale-up of Stool-Based Xpert
Testing to Diagnose Tuberculosis in Children.
Emerg Infect Dis. 2025;31:1-9. PubMedAbstract available
GERUSSI V, Petersen T, Bonnet I, Aubry A, et al Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.
Emerg Infect Dis. 2025;31:633-636. PubMedAbstract available
FRANCISCO NM, Gaviraghi A, Alladio F, Huits R, et al Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda,
Angola.
Emerg Infect Dis. 2025;31:627-629. PubMedAbstract available
KONSTANTYNOVSKA O, Synenko T, Honcharenko A, Volobuieva O, et al Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine,
2019-2023.
Emerg Infect Dis. 2025;31:615-617. PubMedAbstract available
JUNG E, Alarcon VA, Solis Tupes WS, Avalos-Cruz T, et al National Active Case-Finding Program for Tuberculosis in Prisons, Peru, 2024.
Emerg Infect Dis. 2025;31:564-568. PubMedAbstract available
SHRESTHA S, Cilloni L, Asay GRB, Kammerer JS, et al Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis
Outbreak Investigations, United States.
Emerg Infect Dis. 2025;31:497-506. PubMedAbstract available
ZIMENKOV D, Ushtanit A, Gordeeva E, Guselnikova E, et al High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium
tuberculosis Isolates, Russia.
Emerg Infect Dis. 2025;31:525-536. PubMedAbstract available
KURBATOVA EV, Whitworth WC, Peddareddy LP, Phillips PPJ, et al Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in
Persons with Diabetes.
Emerg Infect Dis. 2025;31:467-476. PubMedAbstract available
November 2024
GORVETZIAN S, Pacheco AG, Anderson E, Ray SM, et al Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019.
Emerg Infect Dis. 2024;30:2261-2270. PubMedAbstract available
August 2024
MCQUAID CF, Ryckman TS, Menzies NA, White RG, et al Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
Emerg Infect Dis. 2024;30:1571-1579. PubMedAbstract available
July 2024
LUKOYE D, Kalamya JN, Awor AC, Gustavson G, et al Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived
of Liberty, Uganda, 2020.
Emerg Infect Dis. 2024;30:1402-1405. PubMedAbstract available
June 2024
TAN Q, Huang CC, Becerra MC, Calderon R, et al Chest Radiograph Screening for Detecting Subclinical Tuberculosis in Asymptomatic
Household Contacts, Peru.
Emerg Infect Dis. 2024;30:1115-1124. PubMedAbstract available
April 2024
FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
Emerg Infect Dis. 2024;30:1-5. PubMedAbstract available
DAHL VN, Butova T, Rosenthal A, Grinev A, et al Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and
Ukraine, 2017-2022.
Emerg Infect Dis. 2024;30:831-833. PubMedAbstract available
GURREY SO, Strick LB, Dov LK, Miller JS, et al Lessons Learned from Public Health and State Prison Collaborations during
COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
Emerg Infect Dis. 2024;30:S17-S20. PubMedAbstract available
March 2024
SPIES R, Hong HN, Trieu PP, Lan LK, et al Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of
Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
Emerg Infect Dis. 2024;30:499-509. PubMedAbstract available
GUNTHER G, Mhuulu L, Diergaardt A, Dreyer V, et al Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant
Tuberculosis, Namibia.
Emerg Infect Dis. 2024;30:568-571. PubMedAbstract available
January 2024
HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with
COVID-19, California, USA, 2020.
Emerg Infect Dis. 2024;30:136-140. PubMedAbstract available
HUMAYUN M, Mukasa L, Ye W, Bates JH, et al Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA,
2010-2021.
Emerg Infect Dis. 2024;30:116-124. PubMedAbstract available
NSENGIYUMVA NP, Khan A, Gler MMTS, Tonquin ML, et al Costs of Digital Adherence Technologies for Tuberculosis Treatment Support,
2018-2021.
Emerg Infect Dis. 2024;30:79-88. PubMedAbstract available
December 2023
LAFLEUR M, Rasoanaivo HA, Andrianarivo TH, Andrianomanana FR, et al Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022.
Emerg Infect Dis. 2023;29:2587-2589. PubMedAbstract available
November 2023
MODONGO C, Barilar I, Wang Q, Molefi T, et al Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF,
Botswana.
Emerg Infect Dis. 2023;29:2403-2406. PubMedAbstract available
October 2023
WINSTON CA, Marks SM, Carr W Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United
States.
Emerg Infect Dis. 2023;29:2102-2104. PubMedAbstract available
August 2023
NABITY SA, Marks SM, Goswami ND, Smith SR, et al Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in
Cross-Sectional Sample from 25 Jurisdictions, United States.
Emerg Infect Dis. 2023;29. PubMedAbstract available
LOUIE JK, Agraz-Lara R, Romo L, Deiterich C, et al Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California,
USA.
Emerg Infect Dis. 2023;29:1651-1654. PubMedAbstract available
July 2023
WOODRUFF R, Miramontes R Tuberculosis Infection among Non-US-Born Persons and Persons >/=60 Years of Age,
United States, 2019-2020.
Emerg Infect Dis. 2023;29:1470-1472. PubMedAbstract available
May 2023
NOROC E, Chesov D, Merker M, Groschel MI, et al Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
Emerg Infect Dis. 2023;29:1046-1050. PubMedAbstract available
NGUYEN HV, Brals D, Tiemersma E, Gasior R, et al Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam,
2017-2018.
Emerg Infect Dis. 2023;29:967-976. PubMedAbstract available
BAKER CR, Barilar I, de Araujo LS, Rimoin AW, et al Use of High-Resolution Geospatial and Genomic Data to Characterize Recent
Tuberculosis Transmission, Botswana.
Emerg Infect Dis. 2023;29:977-987. PubMedAbstract available
MILLARD J, Rimmer S, Nimmo C, O'Donnell M, et al Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in
Treatment of Drug-Resistant TB.
Emerg Infect Dis. 2023;29:1081-1084. PubMedAbstract available